GSI Pill: pink, capsule/oblong, 19mm
Generic Name: emtricitabine/rilpivirine/tenofovir disoproxil
The pill with imprint GSI (Pink, Capsule/Oblong, 19mm) has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg and is used for HIV Infection. It belongs to the drug class antiviral combinations and is not a controlled substance.
Images for GSI
Complera
- Generic Name
- emtricitabine/rilpivirine/tenofovir disoproxil
- Imprint
- GSI
- Strength
- emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
- Color
- Pink
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-1101
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
polysorbate 20,
croscarmellose sodium,
magnesium stearate,
corn starch,
FD&C Blue No. 2,
aluminum oxide,
ferric oxide red,
FD&C Yellow No. 6,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "GSI"
More about Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiviral combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.